2026 Plan for Issuance of A-Shares to Specific Targets of CGN Nuclear Technology Development Co., Ltd.

[Image: CGN logo]

Stock Code: 000881 Stock Abbreviation: CGN Nuclear Technology

CGN Nuclear Technology Development Co., Ltd.

2026 Plan for Issuance of A-Shares to Specific Targets

July 2026

Company Statement

1. The Company and all members of the Board of Directors guarantee that the contents of this plan are true, accurate, and complete, and confirm that there are no false records, misleading statements, or major omissions.

2. This plan is prepared in accordance with the Company Law, the Securities Law, the Administrative Measures for the Issuance of Securities by Listed Companies, and other requirements.

3. Upon completion of this issuance, the Company is solely responsible for changes in its operations and earnings; investors are solely responsible for investment risks arising from this issuance.

4. This plan is an explanation of this issuance by the Board of Directors; any statements to the contrary are false.

5. The matters described in this plan do not represent a substantive judgment, confirmation, audit, or registration by the approval authorities regarding the matters related to this issuance. The effectiveness and completion of the matters related to this issuance are still subject to the approval of the competent state-owned assets supervision unit, the approval of the Company's general meeting of shareholders, the approval of the waiver of the tender offer for the subscriber, and the approval of the Shenzhen Stock Exchange and the registration by the China Securities Regulatory Commission.

6. If investors have any questions, they should consult their stockbroker, lawyer, professional accountant, or other professional advisor.

Important Notice

1. The matters related to this issuance have been deliberated and approved at the Fourth Meeting of the Eleventh Board of Directors of the Company held on July 9, 2026. They are still subject to the approval of the competent state-owned assets supervision unit, the approval of the Company's general meeting of shareholders, the approval of the waiver of the tender offer for the subscriber, and the approval of the Shenzhen Stock Exchange and the registration by the China Securities Regulatory Commission before they can be implemented.

2. The target of this issuance is CGN Nuclear Technology Application Co., Ltd., which intends to subscribe for all the shares issued by the Company in this issuance in cash. CGN Nuclear Technology Application Co., Ltd. has signed a "Conditional Share Subscription Agreement" with the Company.

3. This issuance constitutes a related party transaction. The Company will strictly comply with laws, regulations, and internal company rules to perform the approval and disclosure procedures for related party transactions.

4. The pricing benchmark date for this issuance is the first day of the issuance period. The issue price of the shares in this issuance shall not be lower than 80% of the average trading price of the Company's shares for the 20 trading days preceding the pricing benchmark date (average trading price for the 20 trading days preceding the pricing benchmark date = total trading volume of the Company's shares for the 20 trading days preceding the pricing benchmark date / total trading volume of the Company's shares for the 20 trading days preceding the pricing benchmark date), and shall not be lower than the audited net assets per share attributable to ordinary shareholders of the parent company as of the end of the most recent period before this issuance.

5. If the Company's shares are subject to ex-rights or ex-dividend matters such as dividend distribution, bonus shares, or capitalization of capital reserves between the pricing benchmark date and the issuance date, the issue price of this issuance will be adjusted accordingly.

6. The total amount of funds to be raised in this issuance is not less than 850 million RMB (inclusive) and not more than 1.25 billion RMB (inclusive). The net proceeds after deducting issuance expenses will be used to supplement working capital or repay bank loans. If the total amount of funds raised from this issuance to specific targets is adjusted due to changes in regulatory policies or requirements of the issuance registration documents, it will be adjusted accordingly at that time.